Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method

References

• Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Save T, Venkitachalam P. (1992). Studies on solid dispersions of nifedipine. Drug Dev Ind Pharm, 18:1663–1679.
   Web of Science ®Google Scholar
• Shah JS, Chen JR, Chow D. (1995). Preformulation study of etoposide: enhanced solubility and dissolution rate by solid-solid dispersions. Int J Pharm, 113:103–111.
   Web of Science ®Google Scholar
• Okimoto K, Miyake M, Ibiki R, Yasumura M, Ohnishi N, Nakai T. (1997). Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. Int J Pharm, 159:85–93.
   Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1998). Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull, 46:482–487.
   PubMed Web of Science ®Google Scholar
• Palanisamy M, Khanam J. (2011). Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373–386.
   PubMed Web of Science ®Google Scholar
• Dinunzio JC, Schilling SU, Coney AW, Hughey JR, Kaneko N, McGinity JW. (2012). Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion. Drug Dev Ind Pharm, 38:180–189.
   PubMed Web of Science ®Google Scholar
• Shanmugam S, Park JH, Chi SC, Yong CS, Choi HG, Woo JS. (2011). Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process. Drug Dev Ind Pharm, 37:628–637.
   PubMed Web of Science ®Google Scholar
• Chow AHL, Hsia CK, Gordon JD, Young JWM, Vargha-Butler EI. (1995). Assessment of wettability and its relationship to the intrinsic dissolution rate of doped phenytoin crystals. Int J Pharm, 126:21–28.
   Web of Science ®Google Scholar
• Perng CY, Kearney AS, Patel K, Palepu NR, Zuber G. (1998). Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int J Pharm, 176:31–38.
   Web of Science ®Google Scholar
• Murdande SB, Pikal MJ, Shanker RM, Bogner RH. (2010). Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. J Pharm Sci, 99:1254–1264.
   PubMed Web of Science ®Google Scholar
• Gupta P, Kakumanu VK, Bansal AK. (2004). Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res, 21:1762–1769.
   PubMed Web of Science ®Google Scholar
• Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M et al. (2005). Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci, 25:313–320.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Shamblin SL, Taylor LS. (2006). Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res, 23:2417–2426.
   PubMed Web of Science ®Google Scholar
• Rumondor AC, Ivanisevic I, Bates S, Alonzo DE, Taylor LS. (2009). Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res, 26:2523–2534.
   PubMed Web of Science ®Google Scholar
• Rumondor AC, Stanford LA, Taylor LS. (2009). Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res, 26:2599–2606.
   PubMed Web of Science ®Google Scholar
• Imaizumi H, Nambu N, Nagai T. (1983). Stabilization of amorphous state of indomethacin by solid dispersion in polyvinylpolypyrrolidone. Chem Pharm Bull, 31:2510–2512.
   Web of Science ®Google Scholar
• Sekizaki H, Danjo K, Eguchi H, Yonezawa Y, Sunada H, Ostuka A. (1995). Solid-state interaction of ibuprofen with polyvinylpolypyrrolidone. Chem Pharm Bull, 43:988–993.
   Web of Science ®Google Scholar
• Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691–1698.
   PubMed Web of Science ®Google Scholar
• Geppi M, Guccione S, Mollica G, Pignatello R, Veracini CA. (2005). Molecular properties of ibuprofen and its solid dispersions with Eudragit RL100 studied by solid-state nuclear magnetic resonance. Pharm Res, 22:1544–1555.
   PubMed Web of Science ®Google Scholar
• Pongpeerapat A, Higashi K, Tozuka Y, Moribe K, Yamamoto K. (2006). Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR. Pharm Res, 23:2566–2574.
   PubMed Web of Science ®Google Scholar
• Kushida I, Ichikawa M, Asakawa N. (2002). Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion. J Pharm Sci, 91:258–266.
   PubMed Web of Science ®Google Scholar
• Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. (2000). Solid-state study of polymorphic drugs: carbamazepine. J Pharm Biomed Anal, 23:41–54.
   PubMed Web of Science ®Google Scholar
• Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. (1991). The Handbook of Infrared and Raman Characteristic Frequencies of Organic Molecules. New York: Academic Press.
   Google Scholar
• Tang XC, Pikal MJ, Taylor LS. (2002). A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers. Pharm Res, 19:477–483.
   PubMed Web of Science ®Google Scholar
• Ando S, Ando I, Shoji A, Ozaki T. (1988). Intermolecular hydrogen-bonding effect on 13C NMR chemical shifts of glycine residue carbonyl carbons of peptide in the solid state. J Am Chem Soc, 110:3380–3386
   Web of Science ®Google Scholar
• Morzycki JW, Wawer I, Gryszkiewicz A, Maj J, Siergiejczyk L, Zaworska A. (2002). 13C-NMR study of 4-azasteroids in solution and solid state. Steroids, 67:621–626.
   PubMed Web of Science ®Google Scholar